Skip to main content
. Author manuscript; available in PMC: 2009 Jul 31.
Published in final edited form as: Lab Chip. 2008 Oct 24;8(12):2105–2112. doi: 10.1039/b810329a

Fig. 5.

Fig. 5

Specificity of the B lymphocyte interaction with anti-CD19, anti-CD5, and streptavidin modified micropatterns. B lymphocyte specific ligands, anti-CD19, showed a much higher cell capturing rate compared to the non-specific anti-CD5 and streptavidin.